The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Talaris Therapeutics Inc(NASDAQ:TALS)


Talaris Therapeutics, Inc. is a late-clinical stage biopharmaceutical company developing investigational, one-time, allogeneic cell therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant bloo...
Website: https://talaristx.com/
Founded: 1998
CEO: Scott Requadt
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Share this website to your friends
Talaris Therapeutics Op Cashflow Per Share ttm
Talaris Therapeutics Free Cashflow Per Share ttm
Talaris Therapeutics Cash Per Share ttm
Talaris Therapeutics (GAAP) P/E ratio ttm
Talaris Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.